1,2,3-Trioctanoyl-rac-glycerol-13C3 (Synonyms: Glycerol Trioctanoate-13C3, TG(8:0/8:0/8:0)-13C3, Trioctanoin-13C3) |
カタログ番号GC46009 |
1,2,3-トリオクタノイルグリセロール-13C3の定量化のための内部標準
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 65402-55-3
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
1,2,3-トリオクタノイルラックグリセロール13C3は、GCまたはLC-MSによる1,2,3-トリオクタノイルラックグリセロールの定量化のための内部標準として使用することを目的としています。 1,2,3-トリオクタノイルラックグリセロールは、sn-1、sn-2、およびsn-3位置にオクタン酸を含む三アシルグリセロールです。 1,2,3-トリオクタノイルラックグリセロールの食事摂取は、マウスにおいて海馬中の糖代謝物質であるグルコース6-リン酸、フルクトース6-リン酸、β-ヒドロキシ酪酸及び6 Hz精神運動性発作試験における発作閾値を増加させます。 1,2,3-Trioctanoyl-rac-glycerolを含む製剤は、化粧品製品で増粘剤や皮膚調整剤として使用されています。
|1. McDonald, T.S., Tan, K.N., Hodson, M.P., et al. Alterations of hippocampal glucose metabolism by even versus uneven medium chain triglycerides. J. Cereb. Blood Flow Metab. 34(1), 153-160 (2014).
|1.マクドナルド、T.S.、タン、K.N.、ホッドソン、M.P。他。均等対非均等中鎖脂肪酸による海馬のグルコース代謝の変化。J.Cereb.Blood Flow Metab。34(1)、153-160(2014)。Cas No. | 65402-55-3 | SDF | |
同義語 | Glycerol Trioctanoate-13C3, TG(8:0/8:0/8:0)-13C3, Trioctanoin-13C3 | ||
Canonical SMILES | O=[13C](CCCCCCC)OCC(O[13C](CCCCCCC)=O)CO[13C](CCCCCCC)=O | ||
Formula | C24[13C3]H50O6 | M.Wt | 473.7 |
溶解度 | DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 20 mg/ml | Storage | Store at -20°C |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.111 mL | 10.5552 mL | 21.1104 mL |
5 mM | 0.4222 mL | 2.111 mL | 4.2221 mL |
10 mM | 0.2111 mL | 1.0555 mL | 2.111 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Average Rating: 5
(Based on Reviews and 34 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *